Citation: Tmt. Mulders et al., SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF A NOVEL, SELECTIVE ANTIPROGESTAGEN (ORG31710) IN HEALTHY MALE-VOLUNTEERS, Contraception, 58(1), 1998, pp. 39-44
Citation: Iwg. Bobbink et al., GLYCATION OF VITRONECTIN AFFECTS ITS TEMPLATE FUNCTION IN PLASMINOGENACTIVATION, RESULTING IN INCREASED PLASMIN ACTIVITY, Thrombosis and haemostasis, 1997, pp. 1442-1442
Citation: Iwg. Bobbink et al., EFFECT OF EXTRACELLULAR-MATRIX GLYCATION ON ENDOTHELIAL-CELL ADHESIONAND SPREADING - INVOLVEMENT OF VITRONECTIN, Diabetes, 46(1), 1997, pp. 87-93
Citation: Iwg. Bobbink et al., GLYCATION OF EXTRACELLULAR-MATRIX PROTEINS RESULTS IN DECREASED ADHESION AND SPREADING OF ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 904-904
Citation: Jd. Oosting et al., ANTIPHOSPHOLIPID ANTIBODIES DIRECTED AGAINST A COMBINATION OF PHOSPHOLIPIDS WITH PROTHROMBIN, PROTEIN-C OR PROTEIN-S - AN EXPLANATION FOR THEIR PATHOGENIC MECHANISM, Thrombosis and haemostasis, 69(6), 1993, pp. 1012-1012
Citation: Jd. Oosting et al., ANTIPHOSPHOLIPID ANTIBODIES DIRECTED AGAINST A COMBINATION OF PHOSPHOLIPIDS WITH PROTHROMBIN, PROTEIN-C, OR PROTEIN-S - AN EXPLANATION FOR THEIR PATHOGENIC MECHANISM, Blood, 81(10), 1993, pp. 2618-2625